Amwell to Participate in Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--Amwell (NYSE: AMWL), a digital healthcare leader, announced key participation in upcoming investor conferences. On November 10, 2022, CEO Dr. Ido Schoenberg and CFO Bob Shepardson will attend the Credit Suisse Healthcare Conference, hosting a fireside chat at 8:30 a.m. PT. Shepardson will also engage in meetings at the Needham & Co. Virtual Health Tech One-on-One Conference on November 15 and at BTIG's Virtual Healthcare Day on November 21. They will meet investors again on November 30 at the Piper Sandler Healthcare Conference in New York City.
- None.
- None.
-
On
November 10, 2022 , Dr.Ido Schoenberg , Chairman and CEO, andBob Shepardson , CFO, will attend the Credit Suisse 31st Annual Healthcare Conference in Palos Verdes, CA, and will participate in an in-person fireside chat at8:30 a.m. PT . They will also conduct one-on-one meetings with investors that day. -
On
November 15, 2022 ,Mr. Shepardson will participate in one-on-one meetings at the First Annual Virtual Health Tech One onOne Conference , hosted byNeedham & Co. -
On
November 21, 2022 ,Mr. Shepardson will host one-on-one meetings at the BTIG Virtual Healthcare Day. -
On
November 30, 2022 ,Dr. Schoenberg andMr. Shepardson will also participate in an in-person fireside chat at the Piper Sandler 34th Annual Healthcare Conference inNew York City and conduct one-on-one meetings with investors. The fireside chat time is to be determined. Please visit https://investors.amwell.com for updated timing closer to the event date.
Audio webcasts will be available following, at https://investors.amwell.com.
About Amwell
Amwell is a leading digital care delivery enablement platform in
Forward-Looking Statements
This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our most recent form 10-K filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005067/en/
Media:
press@amwell.com
Investors:
sue.dooley@amwell.com
415-602-9167
Source: Amwell
FAQ
What investor conferences will Amwell (AMWL) participate in November 2022?
Who will represent Amwell at the Credit Suisse Healthcare Conference?
When is Amwell's fireside chat at the Credit Suisse Healthcare Conference?
Where can I find audio webcasts of Amwell's conference presentations?